General characteristics and clinical data of the subjects included in the study. حسب Spela Kokelj (8356644)

الموضوعات:

Distribution of average relative amounts of lipid classes. حسب Spela Kokelj (8356644)

الموضوعات:

Flow chart on the inclusion and drop out of patients. حسب Spela Kokelj (8356644)

الموضوعات:

Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls. حسب Spela Kokelj (8356644)

الموضوعات:

Symptoms reported by COVID-19 cases at baseline and at follow-up. حسب Spela Kokelj (8356644)

الموضوعات:

Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means. حسب Mohammad Bakhtiari (11838264)

Effects of BM-MSCs on ROS generation in DCS rats. حسب Chen Lu (135200)

الموضوعات:

Pretreatment of BM-MSCs attenuates DCS induced lung inflammation. حسب Chen Lu (135200)

الموضوعات:

Isotype control overlays. حسب Chen Lu (135200)

الموضوعات:

Original uncropped blot. حسب Chen Lu (135200)

الموضوعات:

Characterization of BM-MSC. حسب Chen Lu (135200)

الموضوعات:

Pretreatment of BM-MSCs improves the survival rate and incidence of DCS. حسب Chen Lu (135200)

الموضوعات:

Utilization of anticoagulants at eight hospitals from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

Identification of BM-MSCs. حسب Chen Lu (135200)

الموضوعات:

Effect of BM-MSCs in improving DCS induced lung injury. حسب Chen Lu (135200)

الموضوعات:

Inpatient utilization of anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

Indications for warfarin prescription in outpatients and inpatients in 2023. حسب Wei Luo (80175)

الموضوعات:

Outpatient utilization of anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

Effects of BM-MSCs on different types of lung cell death in different group. حسب Chen Lu (135200)

الموضوعات:

DDC for four anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات: